E2F1 and gastric cancer: Bargiela-Iparraguirre et al. demonstrated that Chk1 overexpression specifically increases resistance to chemo/radiotherapy in gastric cancer and that Chk1 expression is controlled by Rb/E2F1 at the transcriptional level22.